Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInsmed Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.98 | -$0.71 | -$0.84 |
| Q2 2026 | 1 | -$0.75 | -$0.50 | -$0.66 |
| Q3 2026 | 1 | -$0.57 | -$0.39 | -$0.50 |
| Q4 2026 | 1 | -$0.31 | -$0.21 | -$0.27 |
| Q1 2027 | 1 | -$0.39 | -$0.26 | -$0.34 |
| Q2 2027 | 1 | -$0.23 | -$0.16 | -$0.20 |
| Q3 2027 | 1 | -$0.06 | -$0.04 | -$0.05 |
| Q4 2027 | 1 | $0.07 | $0.11 | $0.09 |
Insmed Inc Earnings Date And Information
Insmed Inc last posted its earnings results on Thursday, February 19th, 2026. The company reported $-1.53758 earnings per share for the quarter, missing analysts' consensus estimates of $-1.07 by $0.46758. The company had revenue of 263.84 M for the quarter and had revenue of 606.42 M for the year. Insmed Inc has generated $-6 earnings per share over the last year ($-6.42 diluted earnings per share) and currently has a price-to-earnings ratio of -26.48. Insmed Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Insmed Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 2025 | -$1.07 | -$1.54 | -0.47 | N/A | $263.84 M |
| 10/30/2025 | Q3 2025 | -$1.33 | -$1.75 | -0.42 | $115.45 M | $142.34 M |
| 08/07/2025 | Q2 2025 | -$1.30 | -$1.70 | -0.4 | $104.13 M | $107.42 M |
| 05/08/2025 | Q1 2025 | -$1.34 | -$1.42 | -0.08 | N/A | $92.82 M |
| 02/20/2025 | Q4 2024 | -$1.17 | -$1.32 | -0.15 | N/A | $104.44 M |
| 10/31/2024 | Q3 2024 | -$1.20 | -$1.27 | -0.07 | $93.36 M | $93.43 M |
| 08/08/2024 | Q2 2024 | -$1.24 | -$1.94 | -0.7 | $87.95 M | $90.34 M |
| 05/09/2024 | Q1 2024 | -$1.24 | -$1.06 | 0.18 | N/A | $75.50 M |
| 02/22/2024 | Q4 2023 | -$1.13 | -$1.28 | -0.15 | N/A | $83.69 M |
| 10/26/2023 | Q3 2023 | -$1.06 | -$1.11 | -0.05 | N/A | $79.07 M |
| 08/03/2023 | Q2 2023 | -$1.10 | -$1.78 | -0.68 | N/A | $77.23 M |
| 05/04/2023 | Q1 2023 | -$1.08 | -$1.17 | -0.09 | N/A | $65.21 M |
| 02/23/2023 | Q4 2022 | -$1.00 | -$1.21 | -0.21 | N/A | $59.30 M |
| 10/27/2022 | Q3 2022 | -$0.89 | -$1.09 | -0.2 | N/A | $67.73 M |
| 08/04/2022 | Q2 2022 | -$0.89 | -$0.80 | 0.09 | N/A | $65.22 M |
| 05/05/2022 | Q1 2022 | -$0.91 | -$0.80 | 0.11 | N/A | $53.11 M |
| 02/17/2022 | Q4 2021 | -$0.89 | -$0.95 | -0.06 | N/A | $56.12 M |
| 10/28/2021 | Q3 2021 | -$0.83 | -$0.96 | -0.13 | N/A | $46.76 M |
| 08/05/2021 | Q2 2021 | -$0.85 | -$1.07 | -0.22 | N/A | $45.37 M |
| 05/06/2021 | Q1 2021 | -$0.91 | -$0.89 | 0.02 | N/A | $40.21 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Insmed Inc Earnings: FAQ's
The conference call for Insmed Inc's latest earnings report can be listened to online.
The conference call transcript for Insmed Inc's latest earnings report can be read online.
Insmed Inc (:INSM) has a recorded annual revenue of $606.42 M.
Insmed Inc (:INSM) has a recorded net income of $-1,276,775,000.Insmed Inc has generated $-6.42 earnings per share over the last four quarters.
Insmed Inc (:INSM) has a price-to-earnings ratio of -26.48 and price/earnings-to-growth ratio is 7.45.